178 related articles for article (PubMed ID: 20161975)
1. Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C.
Fagerholm AE; Habrant D; Koskinen AM
Mar Drugs; 2010 Jan; 8(1):122-72. PubMed ID: 20161975
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein phosphatase-1 by clavosines A and B. Novel members of the calyculin family of toxins.
McCready TL; Islam BF; Schmitz FJ; Luu HA; Dawson JF; Holmes CF
J Biol Chem; 2000 Feb; 275(6):4192-8. PubMed ID: 10660582
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
Fujiki H; Suganuma M
Prog Mol Subcell Biol; 2009; 46():221-54. PubMed ID: 19184590
[TBL] [Abstract][Full Text] [Related]
5. Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.
Takai A; Eto M; Hirano K; Takeya K; Wakimoto T; Watanabe M
J Physiol Sci; 2018 Jan; 68(1):1-17. PubMed ID: 28681362
[TBL] [Abstract][Full Text] [Related]
6. PP1/PP2A phosphatase inhibition-induced metaplasticity in protein synthesis blocker-treated hippocampal slices: LTP and LTD, or There and Back again.
Maltsev AV; Balaban PM
Biochem Biophys Res Commun; 2021 Jun; 558():64-70. PubMed ID: 33901925
[TBL] [Abstract][Full Text] [Related]
7. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
9. Polyketides from marine dinoflagellates of the genus Prorocentrum, biosynthetic origin and bioactivity of their okadaic acid analogues.
Hu W; Xu J; Sinkkonen J; Wu J
Mini Rev Med Chem; 2010 Jan; 10(1):51-61. PubMed ID: 20105116
[TBL] [Abstract][Full Text] [Related]
10. The binding mode of calyculin A to protein phosphatase-1. A novel spiroketal vector model.
Lindvall MK; Pihko PM; Koskinen AM
J Biol Chem; 1997 Sep; 272(37):23312-6. PubMed ID: 9287341
[TBL] [Abstract][Full Text] [Related]
11. NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.
Dynia DW; Steinmetz AG; Kocinsky HS
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F745-53. PubMed ID: 20015946
[TBL] [Abstract][Full Text] [Related]
12. Human and rat hepatocyte toxicity and protein phosphatase 1 and 2A inhibitory activity of naturally occurring desmethyl-microcystins and nodularins.
Ufelmann H; Krüger T; Luckas B; Schrenk D
Toxicology; 2012 Mar; 293(1-3):59-67. PubMed ID: 22230684
[TBL] [Abstract][Full Text] [Related]
13. Phosphocalyculin C as a pyrophosphate protoxin of calyculin C in the marine sponge Discodermia calyx.
Egami Y; Wakimoto T; Abe I
Bioorg Med Chem Lett; 2014 Nov; 24(22):5150-3. PubMed ID: 25442302
[TBL] [Abstract][Full Text] [Related]
14. Calyculins, potent antitumour metabolites from the marine sponge Discodermia calyx: biological activities.
Kato Y; Fusetani N; Matsunaga S; Hashimoto K
Drugs Exp Clin Res; 1988; 14(12):723-8. PubMed ID: 2472940
[TBL] [Abstract][Full Text] [Related]
15. Chiral action at a distance: remote substituent effects on the optical activity of calyculins A and B.
Kondru RK; Beratan DN; Friestad GK; Smith AB; Wipf P
Org Lett; 2000 Jun; 2(11):1509-12. PubMed ID: 10841466
[TBL] [Abstract][Full Text] [Related]
16. Calyculin: Nature's way of making the sponge-derived cytotoxin.
Wakimoto T; Egami Y; Abe I
Nat Prod Rep; 2016 Jun; 33(6):751-60. PubMed ID: 26923942
[TBL] [Abstract][Full Text] [Related]
17. Insight into binding of calyculin A to protein phosphatase 1: isolation of hemicalyculin a and chemical transformation of calyculin A.
Wakimoto T; Matsunaga S; Takai A; Fusetani N
Chem Biol; 2002 Mar; 9(3):309-19. PubMed ID: 11927256
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases.
Yan Y; Mumby MC
J Biol Chem; 1999 Nov; 274(45):31917-24. PubMed ID: 10542219
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.
Yi KD; Simpkins JW
Endocrinology; 2008 Oct; 149(10):5235-43. PubMed ID: 18566123
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the protein phosphatase 2A inhibitor (4S,5S,6S,10S,11S,12S)-cytostatin.
Bialy L; Waldmann H
Angew Chem Int Ed Engl; 2002 May; 41(10):1748-51. PubMed ID: 19750704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
